Study of Growth and Bone Mineral Density in Children With Atopic Dermatitis (AD) Treated With Dupilumab
Clinical trial NCT07187089 · WITHDRAWN
Trial details
- NCT number
- NCT07187089
- Sponsor
- Regeneron Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-11
- Primary completion
- 2027-12-23
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.